Provided by Tiger Trade Technology Pte. Ltd.

GeneDx Holdings

67.73
-0.8000-1.17%
Post-market: 67.730.00000.00%16:00 EDT
Volume:725.69K
Turnover:48.48M
Market Cap:2.01B
PE:-18.61
High:67.94
Open:67.41
Low:64.50
Close:68.53
52wk High:170.87
52wk Low:32.21
Shares:29.68M
Float Shares:20.46M
Volume Ratio:0.96
T/O Rate:3.55%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.6399
EPS(LYR):-0.7339
ROE:-40.80%
ROA:-7.89%
PB:8.23
PE(LYR):-92.28

Loading ...

GUIDANCE: (WGS) GeneDX Expects 2026 Revenue Range $475 Million - $490 Million, vs. FactSet Est of $478.4 Million

MT Newswires Live
·
Aug 04

GeneDx Q2 FY26 GAAP Net Loss Widens to $17.7 Million; Revenue Rises 11% Year over Year to $114.4 Million

Reuters
·
Aug 04

GeneDx Q2 Revenue Beats Analyst Estimates

Reuters
·
Aug 04

GeneDx Hldgs Q2 Adj. EPS $(0.28) Misses $(0.19) Estimate, Sales $114.440M Beat $111.011M Estimate

Benzinga Earnings
·
Aug 04

GeneDx Q2 Revenue USD 114.4 Million Vs. IBES Estimate USD 111 Million

Reuters
·
Aug 04

GeneDx: Q3 2026 Revenue Guidance $122 Mln-$124 Mln

THOMSON REUTERS
·
Aug 04

GeneDx Holdings: Reaffirmed Its Full Year 2026 Guidance

THOMSON REUTERS
·
Aug 04

GeneDx Holdings Corp Q3 REV View $126.1 Mln

THOMSON REUTERS
·
Aug 04

Press Release: GeneDx Reports Second Quarter 2026 Financial Results

Dow Jones
·
Aug 04

GeneDx Stock And 2 Testing Companies In Focus After Cyclospora Outbreak

Simply Wall St.
·
Jul 28

Earning Preview: GeneDx Holdings Q2 revenue is expected to increase by 29.92%, and institutional views are cautiously optimistic

Earnings Agent
·
Jul 27

How GeneDx’s Securities Lawsuit and Fabric Genomics Impairment Will Impact GeneDx Holdings (WGS) Investors

Simply Wall St.
·
Jul 27

Genedx to Report Q2 2026 Results After Market Close, Host Conference Call

Reuters
·
Jul 17

How Investors Are Reacting To GeneDx Holdings (WGS) Class Actions Over Fabric Impairment And Guidance Cut

Simply Wall St.
·
Jul 11

Genedx Holdings is Maintained at Buy by Guggenheim

Dow Jones
·
Jun 29

Is GeneDx (WGS) Elevating Execution Risk or Opportunity With Its New Genomics-Focused President?

Simply Wall St.
·
Jun 29

GeneDx Holdings Is Maintained at Overweight by Piper Sandler

Dow Jones
·
Jun 24

GeneDx holds annual shareholder meeting

Reuters
·
Jun 23

GeneDx Holdings Corp : Piper Sandler Raises Target Price to $63 From $50

THOMSON REUTERS
·
Jun 23

GeneDx President Mark A. Gardner files initial beneficial ownership statement

Reuters
·
Jun 17